Till sidinnehåll
Kunskapsbank för cancervården Till cancercentrum.se

Referenser

Abbas, H., Niazi, M., & Makker, J. (2017). Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Colon: A Case Report and a Literature Review. Am J Case Rep, 18, 491-497. doi:10.12659/ajcr.902843

Agarwal, A., Ranganathan, P., Kattal, N., Pasqualotto, F., Hallak, J., Khayal, S., & Mascha, E. (2004). Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertil Steril, 81(2), 342-348. doi:10.1016/j.fertnstert.2003.07.021

Akasaka, R., Chiba, T., Dutta, A. K., Toya, Y., Mizutani, T., Shozushima, T., . . . Suzuki, K. (2012). Colonic mucosa-associated lymphoid tissue lymphoma. Case Rep Gastroenterol, 6(2), 569-575. doi:10.1159/000342726

Al-Tourah, A. J., Gill, K. K., Chhanabhai, M., Hoskins, P. J., Klasa, R. J., Savage, K. J., . . . Connors, J. M. (2008). Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. J Clin Oncol, 26(32), 5165-5169. 

Altieri, A., Bermejo, J. L., & Hemminki, K. (2005). Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood, 106(2), 668-672. doi:10.1182/blood-2005-01-0140

Ame-Thomas, P., Maby-El Hajjami, H., Monvoisin, C., Jean, R., Monnier, D., Caulet-Maugendre, S., . . . Tarte, K. (2007). Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood, 109(2), 693-702. 

Andritsos, L. A., Grieselhuber, N. R., Anghelina, M., Rogers, K. A., Roychowdhury, S., Reeser, J. W., . . . Grever, M. R. (2018). Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia. Leuk Lymphoma, 59(4), 1008-1011. doi:10.1080/10428194.2017.1365853

Angelopoulou, M. K. (2015). Transformed nodal marginal zone lymphoma versus diffuse large B cell lymphoma: the microRNA aspect. Acta Haematol, 133(2), 212-213. doi:10.1159/000365878

Arcaini, L., Burcheri, S., Rossi, A., Paulli, M., Bruno, R., Passamonti, F., . . . Lazzarino, M. (2007). Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol, 18(2), 346-350. doi:10.1093/annonc/mdl388

Arcaini, L., Lazzarino, M., Colombo, N., Burcheri, S., Boveri, E., Paulli, M., . . . Iannitto, E. (2006). Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood, 107(12), 4643-4649. doi:10.1182/blood-2005-11-4659

Arcaini, L., Lucioni, M., Boveri, E., & Paulli, M. (2009). Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease. Eur J Haematol, 83(3), 165-174. doi:10.1111/j.1600-0609.2009.01301.x

Arcaini, L., Merli, M., Volpetti, S., Rattotti, S., Gotti, M., & Zaja, F. (2012). Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy. Clin Dev Immunol, 2012, 638185. doi:10.1155/2012/638185

Arcaini, L., Montanari, F., Alessandrino, E. P., Tucci, A., Brusamolino, E., Gargantini, L., . . . Lazzarino, M. (2008). Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. Ann Oncol, 19(7), 1331-1335. 

Ardeshna, K. M., Qian, W., Smith, P., Braganca, N., Lowry, L., Patrick, P., . . . Linch, D. C. (2014). Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol, 15(4), 424-435. 

Ardeshna, K. M., Smith, P., Norton, A., Hancock, B. W., Hoskin, P. J., MacLennan, K. A., . . . Linch, D. C. (2003). Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet, 362(9383), 516-522. 

Aukema, S. M., Siebert, R., Schuuring, E., van Imhoff, G. W., Kluin-Nelemans, H. C., Boerma, E. J., & Kluin, P. M. (2011). Double-hit B-cell lymphomas. Blood, 117(8), 2319-2331. 

Avivi, I., Arcaini, L., Ferretti, V. V., Boumendil, A., Finel, H., Milone, G., . . . Conconi, A. (2018). High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO. Br J Haematol, 182(6), 807-815. doi:10.1111/bjh.15454

Ayyappan, S., & William, B. M. (2018). Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy. Curr Oncol Rep, 20(4), 33. doi:10.1007/s11912-018-0687-9

Bahler, D. W., & Levy, R. (1992). Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acad Sci U S A, 89(15), 6770-6774. 

Ban-Hoefen, M., Vanderplas, A., Crosby-Thompson, A. L., Abel, G. A., Czuczman, M. S., Gordon, L. I., . . . Friedberg, J. W. (2013). Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database. Br J Haematol, 163(4), 487-495. 

Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Mueller, S. P., . . . Cheson, B. D. (2014). Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol, 32(27), 3048-3058. 

Behl, D., Ristow, K., Markovic, S. N., Witzig, T. E., Habermann, T. M., Colgan, J. P., . . . Porrata, L. F. (2007). Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas. Br J Haematol, 137(5), 409-415. 

Bende, R. J., Smit, L. A., & van Noesel, C. J. (2007). Molecular pathways in follicular lymphoma. Leukemia, 21(1), 18-29. 

Bensinger, W. I., Holmberg, L., Gooley, T. A., Till, B. G., Budde, L. E., Pagel, J. M., . . . Gopal, A. K. (2013). Bendamustine (Treanda®)-Based Regimens Are Effective In Mobilizing Peripheral Blood Hematopoietic Stem Cells For Autologous Transplantation. Blood, 122, 2033-2033. 

Bentley, G., Palutke, M., & Mohamed, A. N. (2005). Variant t(14;18) in malignant lymphoma: a report of seven cases. Cancer Genet Cytogenet, 157(1), 12-17. 

Borie, R., Wislez, M., Antoine, M., Copie-Bergman, C., Thieblemont, C., & Cadranel, J. (2016). Pulmonary mucosa-associated lymphoid tissue lymphoma revisited. Eur Respir J, 48(4), 1252. doi:10.1183/13993003.01143-2016

Bracci, P. M., Benavente, Y., Turner, J. J., Paltiel, O., Slager, S. L., Vajdic, C. M., . . . de Sanjose, S. (2014). Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr, 2014(48), 52-65. doi:10.1093/jncimonographs/lgu011

Brice, P., Bastion, Y., Lepage, E., Brousse, N., Haioun, C., Moreau, P., . . . Solal-Celigny, P. (1997). Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol, 15(3), 1110-1117. 

Brodtkorb, M., Lingjaerde, O. C., Huse, K., Troen, G., Hystad, M., Hilden, V. I., . . . Smeland, E. B. (2014). Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma. Blood, 123(7), 1051-1054. 

Buske, C., Hoster, E., Dreyling, M., Hasford, J., Unterhalt, M., & Hiddemann, W. (2006). The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome. Blood, 108(5), 1504-1508. 

Cancer prevention. Retrieved from http://www.who.int/cancer/prevention/en/ 

Canioni, D., Salles, G., Mounier, N., Brousse, N., Keuppens, M., Morchhauser, F., . . . Xerri, L. (2008). High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol, 26(3), 440-446. 

Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W., & Tubiana, M. (1971). Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res, 31(11), 1860-1861. 

Carreras, J., Lopez-Guillermo, A., Fox, B. C., Colomo, L., Martinez, A., Roncador, G., . . . Banham, A. H. (2006). High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood, 108(9), 2957-2964. 

Carreras, J., Lopez-Guillermo, A., Roncador, G., Villamor, N., Colomo, L., Martinez, A., . . . Campo, E. (2009). High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol, 27(9), 1470-1476. 

Casulo, C., & Barr, P. M. (2019). How I treat early-relapsing follicular lymphoma. Blood, 133(14), 1540-1547. doi:10.1182/blood-2018-08-822148

Cheah, C. Y., & Fowler, N. H. (2016). Idelalisib in the management of lymphoma. Blood, 128(3), 331-336. doi:10.1182/blood-2016-02-702761

Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., & Lister, T. A. (2014). Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol, 32(27), 3059-3068. 

Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014). Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol, 32(27), 3059-3068. doi:10.1200/jco.2013.54.8800

Choi, J. Y., Chung, J. H., Park, Y. J., Jung, G. Y., Yoon, T. W., Kim, Y. J., . . . Nam, S. H. (2016). Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Tissue Type Involving the Dura. Cancer Res Treat, 48(2), 859-863. doi:10.4143/crt.2014.334

Christie, L., Kernohan, N., Levison, D., Sales, M., Cunningham, J., Gillespie, K., . . . Goodlad, J. (2008). C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator? Leuk Lymphoma, 49(3), 470-476. 

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. (1997). Blood, 89(11), 3909-3918. 

Cocco, P., t'Mannetje, A., Fadda, D., Melis, M., Becker, N., de Sanjose, S., . . . Boffetta, P. (2010). Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study. Occup Environ Med, 67(5), 341-347. doi:10.1136/oem.2009.046839

Cohen, S., Kiss, T., Lachance, S., Roy, D. C., Sauvageau, G., Busque, L., . . . Roy, J. (2012). Tandem autologous-allogeneic nonmyeloablative sibling transplantation in relapsed follicular lymphoma leads to impressive progression-free survival with minimal toxicity. Biol Blood Marrow Transplant, 18(6), 951-957. 

Conconi, A., Ponzio, C., Lobetti-Bodoni, C., Motta, M., Rancoita, P. M., Stathis, A., . . . Zucca, E. (2012). Incidence, risk factors and outcome of histological transformation in follicular lymphoma. Br J Haematol, 157(2), 188-196. 

Consensus resolution: proposed criteria for evaluation of response to treatment in hairy cell leukemia. (1987). Leukemia, 1(4), 405. 

Correia, C., Schneider, P. A., Dai, H., Dogan, A., Maurer, M. J., Church, A. K., . . . Kaufmann, S. H. (2015). BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood, 125(4), 658-667. 

Damaj, G., Verkarre, V., Delmer, A., Solal-Celigny, P., Yakoub-Agha, I., Cellier, C., . . . Hermine, O. (2003). Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann Oncol, 14(4), 623-629. 

Davies, A. J., Rosenwald, A., Wright, G., Lee, A., Last, K. W., Weisenburger, D. D., . . . Andrew Lister, T. (2007). Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol, 136(2), 286-293. 

de Jong, D. (2005). Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol, 23(26), 6358-6363. 

de la Fuente, M. I., Haggiagi, A., Moul, A., Young, R. J., Sidani, C., Markoe, A., . . . Lossos, I. S. (2017). Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences. Leuk Lymphoma, 58(4), 882-888. doi:10.1080/10428194.2016.1218006

Deconinck, E., Foussard, C., Milpied, N., Bertrand, P., Michenet, P., Cornillet-LeFebvre, P., . . . Colombat, P. (2005). High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS. Blood, 105(10), 3817-3823. 

Defrancesco, I., & Arcaini, L. (2018). Overview on the management of non-gastric MALT lymphomas. Best Pract Res Clin Haematol, 31(1), 57-64. doi:10.1016/j.beha.2017.11.001

Del Mastro, L., Ceppi, M., Poggio, F., Bighin, C., Peccatori, F., Demeestere, I., . . . Bruzzi, P. (2014). Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev, 40(5), 675-683. doi:10.1016/j.ctrv.2013.12.001

Dolken, G., Dolken, L., Hirt, C., Fusch, C., Rabkin, C. S., & Schuler, F. (2008). Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals. J Natl Cancer Inst Monogr(39), 44-47. 

Dong, S., Chen, L., Chen, Y., & Chen, X. (2017). Primary hepatic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type: A case report and literature review. Medicine (Baltimore), 96(13), e6305. doi:10.1097/md.0000000000006305

Drake, M. T., Maurer, M. J., Link, B. K., Habermann, T. M., Ansell, S. M., Micallef, I. N., . . . Cerhan, J. R. (2010). Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol, 28(27), 4191-4198. 

Dreyling, M., Santoro, A., Mollica, L., Leppa, S., Follows, G. A., Lenz, G., . . . Zinzani, P. L. (2017). Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma. J Clin Oncol, 35(35), 3898-3905. doi:10.1200/jco.2017.75.4648

Dreyling, M., Thieblemont, C., Gallamini, A., Arcaini, L., Campo, E., Hermine, O., . . . Zucca, E. (2013). ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol, 24(4), 857-877. doi:10.1093/annonc/mds643

Duarte, R. F., Labopin, M., Bader, P., Basak, G. W., Bonini, C., Chabannon, C., . . . Mohty, M. (2019). Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant, 54(10), 1525-1552. doi:10.1038/s41409-019-0516-2

Dunleavy, K. (2014). Double-hit lymphomas: current paradigms and novel treatment approaches. ASH Education Program Book, 2014(1), 107-112. doi:10.1182/asheducation-2014.1.107

Eide, M. B., Lauritzsen, G. F., Kvalheim, G., Kolstad, A., Fagerli, U. M., Maisenholder, M., . . . Holte, H. (2011). High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. Br J Haematol, 152(5), 600-610. 

Ekstrom Smedby, K., Vajdic, C. M., Falster, M., Engels, E. A., Martinez-Maza, O., Turner, J., . . . Cozen, W. (2008). Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood, 111(8), 4029-4038. 

Epron, G., Ame-Thomas, P., Le Priol, J., Pangault, C., Dulong, J., Lamy, T., . . . Tarte, K. (2012). Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling. Leukemia, 26(1), 139-148. 

Farinha, P., Al-Tourah, A., Gill, K., Klasa, R., Connors, J. M., & Gascoyne, R. D. (2010). The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation. Blood, 115(2), 289-295. 

Farinha, P., Masoudi, H., Skinnider, B. F., Shumansky, K., Spinelli, J. J., Gill, K., . . . Gascoyne, R. D. (2005). Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood, 106(6), 2169-2174. 

Fasola, C. E., Jones, J. C., Huang, D. D., Le, Q. T., Hoppe, R. T., & Donaldson, S. S. (2013). Low-dose radiation therapy (2 Gy x 2) in the treatment of orbital lymphoma. Int J Radiat Oncol Biol Phys, 86(5), 930-935. doi:10.1016/j.ijrobp.2013.04.035

Federico, M., Bellei, M., Marcheselli, L., Luminari, S., Lopez-Guillermo, A., Vitolo, U., . . . Solal-Celigny, P. (2009). Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol, 27(27), 4555-4562. 

Federico, M., Caballero Barrigon, M. D., Marcheselli, L., Tarantino, V., Manni, M., Sarkozy, C., . . . Coiffier, B. (2018). Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis. Lancet Haematol, 5(8), e359-e367. doi:10.1016/s2352-3026(18)30090-5

Fischbach, W., Goebeler-Kolve, M. E., Dragosics, B., Greiner, A., & Stolte, M. (2004). Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut, 53(1), 34-37. doi:10.1136/gut.53.1.34

Flinn, I. W., Miller, C. B., Ardeshna, K. M., Tetreault, S., Assouline, S. E., Mayer, J., . . . Zinzani, P. L. (2019). DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma. J Clin Oncol, 37(11), 912-922. doi:10.1200/jco.18.00915

Flinn, I. W., van der Jagt, R., Kahl, B. S., Wood, P., Hawkins, T. E., Macdonald, D., . . . Burke, J. M. (2014). Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study. Blood, 123(19), 2944-2952. doi:10.1182/blood-2013-11-531327

Forero-Torres, A., Ramchandren, R., Yacoub, A., Wertheim, M. S., Edenfield, W. J., Caimi, P., . . . Phillips, T. J. (2019). Parsaclisib, a potent and highly selective PI3Kdelta inhibitor, in patients with relapsed or refractory B-cell malignancies. Blood, 133(16), 1742-1752. doi:10.1182/blood-2018-08-867499

Geyer, J. T., Subramaniyam, S., Jiang, Y., Elemento, O., Ferry, J. A., de Leval, L., . . . Tam, W. (2015). Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. Hum Pathol, 46(2), 260-271. 

Ghesquieres, H., Cartron, G., Seymour, J. F., Delfau-Larue, M. H., Offner, F., Soubeyran, P., . . . Salles, G. (2012). Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. Blood, 120(13), 2650-2657. 

Girinsky, T., Paumier, A., Ferme, C., Hanna, C., Ribrag, V., Leroy-Ladurie, F., & Ghalibafian, M. (2012). Low-dose radiation treatment in pulmonary mucosa-associated lymphoid tissue lymphoma: a plausible approach? A single-institution experience in 10 patients. Int J Radiat Oncol Biol Phys, 83(3), e385-389. doi:10.1016/j.ijrobp.2012.01.005

Glas, A. M., Knoops, L., Delahaye, L., Kersten, M. J., Kibbelaar, R. E., Wessels, L. A., . . . de Jong, D. (2007). Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol, 25(4), 390-398. 

Gopal, A. K., Kahl, B. S., de Vos, S., Wagner-Johnston, N. D., Schuster, S. J., Jurczak, W. J., . . . Salles, G. A. (2014). PI3Kdelta inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med, 370(11), 1008-1018. doi:10.1056/NEJMoa1314583

Grever, M. R., Abdel-Wahab, O., Andritsos, L. A., Banerji, V., Barrientos, J., Blachly, J. S., . . . Falini, B. (2017). Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood, 129(5), 553-560. doi:10.1182/blood-2016-01-689422

Haas, R. L., Poortmans, P., de Jong, D., Aleman, B. M., Dewit, L. G., Verheij, M., . . . Bartelink, H. (2003). High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol, 21(13), 2474-2480. 

Hancock, B. W., Qian, W., Linch, D., Delchier, J. C., Smith, P., Jakupovic, I., . . . Zucca, E. (2009). Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. Br J Haematol, 144(3), 367-375. doi:10.1111/j.1365-2141.2008.07486.x

Harada, K., Murakami, N., Kitaguchi, M., Sekii, S., Takahashi, K., Yoshio, K., . . . Itami, J. (2014). Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys, 88(3), 650-654. doi:10.1016/j.ijrobp.2013.11.235

Harris, N. L., Swerdlow, S. H., Jaffe, E. S., Ott, G., & Nathwani, D. (2008). Follicular lymphoma. In S. H. Swerdlow, E. Campo, N. L. Harris, E. S. Jaffe, S. A. Pileri, H. Stein, J. Thiele, & J. W. Vardiman (Eds.), WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (pp. 220-226). Lyon: IARC.

Hiddemann, W., Barbui, A. M., Canales, M. A., Cannell, P. K., Collins, G. P., Durig, J., . . . Marcus, R. E. (2018). Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety. J Clin Oncol, 36(23), 2395-2404. doi:10.1200/jco.2017.76.8960

Hiddemann, W., Kneba, M., Dreyling, M., Schmitz, N., Lengfelder, E., Schmits, R., . . . Unterhalt, M. (2005). Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood, 106(12), 3725-3732. doi:10.1182/blood-2005-01-0016

Hoglund, M., Sehn, L., Connors, J. M., Gascoyne, R. D., Siebert, R., Sall, T., . . . Horsman, D. E. (2004). Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer, 39(3), 195-204. 

Horning, S. J., & Rosenberg, S. A. (1984). The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med, 311(23), 1471-1475. 

Hoskin, P. J., Kirkwood, A. A., Popova, B., Smith, P., Robinson, M., Gallop-Evans, E., . . . Syndikus, I. (2014). 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. Lancet Oncol, 15(4), 457-463. 

Hovatta, O. (2004). Cryopreservation and culture of human ovarian cortical tissue containing early follicles. Eur J Obstet Gynecol Reprod Biol, 113 Suppl 1, S50-54. doi:10.1016/j.ejogrb.2003.11.012

Inagaki, H., Nakamura, T., Li, C., Sugiyama, T., Asaka, M., Kodaira, J., . . . Nakamura, S. (2004). Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol, 28(12), 1560-1567. 

Jacobson, C. A., & Freedman, A. S. (2012). Early stage follicular lymphoma, current management and controversies. Curr Opin Oncol, 24(5), 475-479. 

Jayakody, N., Harris, E. C., & Coggon, D. (2015). Phenoxy herbicides, soft-tissue sarcoma and non-Hodgkin lymphoma: a systematic review of evidence from cohort and case-control studies. Br Med Bull, 114(1), 75-94. doi:10.1093/bmb/ldv008

Johnson, P. W., Rohatiner, A. Z., Whelan, J. S., Price, C. G., Love, S., Lim, J., . . . Lister, T. A. (1995). Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol, 13(1), 140-147. 

Junlen, H. R., Peterson, S., Kimby, E., Lockmer, S., Linden, O., Nilsson-Ehle, H., . . . Wahlin, B. E. (2015). Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study. Leukemia, 29(3), 668-676. 

Juweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., . . . Cheson, B. D. (2007). Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol, 25(5), 571-578. doi:10.1200/jco.2006.08.2305

Kahl, B. S., Hong, F., Williams, M. E., Gascoyne, R. D., Wagner, L. I., Krauss, J. C., . . . Horning, S. J. (2014). Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402. J Clin Oncol, 32(28), 3096-3102. 

Kanellis, G., Mollejo, M., Montes-Moreno, S., Rodriguez-Pinilla, S. M., Cigudosa, J. C., Algara, P., . . . Piris, M. A. (2010). Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica, 95(7), 1122-1129. doi:10.3324/haematol.2009.013714

Karam, M., Novak, L., Cyriac, J., Ali, A., Nazeer, T., & Nugent, F. (2006). Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer, 107(1), 175-183. doi:10.1002/cncr.21967

Kelley, S. R. (2017). Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature. Int J Colorectal Dis, 32(3), 295-304. doi:10.1007/s00384-016-2734-z

Kelly, J. L., Salles, G., Goldman, B., Fisher, R. I., Brice, P., Press, O., . . . Friedberg, J. W. (2015). Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies. J Clin Oncol, 33(13), 1482-1490. 

Keulers, B. J., Scheltinga, M. R., Houterman, S., Van Der Wilt, G. J., & Spauwen, P. H. (2008). Surgeons underestimate their patients' desire for preoperative information. World J Surg, 32(6), 964-970. doi:10.1007/s00268-008-9581-1

Kiesewetter, B., Willenbacher, E., Willenbacher, W., Egle, A., Neumeister, P., Voskova, D., . . . Raderer, M. (2017). A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma. Blood, 129(3), 383-385. doi:10.1182/blood-2016-06-720599

Kimby, E., Ostenstad, B., Brown, P., Hagberg, H., Erlanson, M., Holte, H., . . . Sundstrom, C. (2015). Two courses of four weekly infusions of rituximab with or without interferon-alpha2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas. Leuk Lymphoma, 1-10. 

Kreitman, R. J., Dearden, C., Zinzani, P. L., Delgado, J., Karlin, L., Robak, T., . . . Giles, F. (2018). Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia. Leukemia, 32(8), 1768-1777. doi:10.1038/s41375-018-0210-1

Kridel, R., Sehn, L. H., & Gascoyne, R. D. (2012). Pathogenesis of follicular lymphoma. J Clin Invest, 122(10), 3424-3431. 

Kunzmann, A. T., Coleman, H. G., Huang, W. Y., & Berndt, S. I. (2018). The association of lifetime alcohol use with mortality and cancer risk in older adults: A cohort study. PLoS Med, 15(6), e1002585. doi:10.1371/journal.pmed.1002585

Larsson, S. C., & Wolk, A. (2011). Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer, 47(16), 2422-2430. doi:10.1016/j.ejca.2011.06.029

Lazarevic, V. L., Hagglund, H., Remberger, M., Wahlin, A., Hallbook, H., Juliusson, G., . . . Johansson, J. E. (2011). Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden. Leuk Lymphoma, 52(1), 69-71. 

Lee, A. M., Clear, A. J., Calaminici, M., Davies, A. J., Jordan, S., Macdougall, F., . . . Goff, L. K. (2006). Number of CD4+ Cells and Location of Forkhead Box Protein P3-Positive Cells in Diagnostic Follicular Lymphoma Tissue Microarrays Correlates With Outcome. J Clin Oncol, 24(31), 5052-5059. 

Lenglet, J., Traulle, C., Mounier, N., Benet, C., Munoz-Bongrand, N., Amorin, S., . . . Thieblemont, C. (2014). Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment. Leuk Lymphoma, 55(8), 1854-1860. doi:10.3109/10428194.2013.861067

Lenz, G., Dreyling, M., Schiegnitz, E., Forstpointner, R., Wandt, H., Freund, M., . . . Hiddemann, W. (2004). Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group. Blood, 104(9), 2667-2674. 

Leonard, J. P., Trneny, M., Izutsu, K., Fowler, N. H., Hong, X., Zhu, J., . . . Gribben, J. G. (2019). AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma. J Clin Oncol, 37(14), 1188-1199. doi:10.1200/jco.19.00010

Leyfman, Y., Joffe, E., Drill, E., Rajeeve, S., Zelenetz, A. D., Palomba, M. L. L., . . . Straus, D. J. (2019). Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT). Blood, 134(Supplement_1), 2826-2826. doi:10.1182/blood-2019-123257

Lindhout, E., Mevissen, M. L., Kwekkeboom, J., Tager, J. M., & de Groot, C. (1993). Direct evidence that human follicular dendritic cells (FDC) rescue germinal centre B cells from death by apoptosis. Clin Exp Immunol, 91(2), 330-336. 

Linet, M. S., Vajdic, C. M., Morton, L. M., de Roos, A. J., Skibola, C. F., Boffetta, P., . . . Chiu, B. C. (2014). Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr, 2014(48), 26-40. 

Ling, D. C., Vargo, J. A., Balasubramani, G. K., & Beriwal, S. (2016). Underutilization of radiation therapy in early-stage marginal zone lymphoma negatively impacts overall survival. Pract Radiat Oncol, 6(4), e97-e105. doi:10.1016/j.prro.2015.11.016

Link, B. K., Maurer, M. J., Nowakowski, G. S., Ansell, S. M., Macon, W. R., Syrbu, S. I., . . . Cerhan, J. R. (2013). Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource. J Clin Oncol, 31(26), 3272-3278. 

Lithner, M., & Zilling, T. (1998). Ôkar preoperativ information patientens välbefinnande postoperativt?: En litteraturstudie. V�rd i Norden, 18(1), 31-33. doi:10.1177/010740839801800106

Liu, H., Ye, H., Ruskone-Fourmestraux, A., De Jong, D., Pileri, S., Thiede, C., . . . Du, M. Q. (2002). T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology, 122(5), 1286-1294. 

Lo Coco, F., Gaidano, G., Louie, D. C., Offit, K., Chaganti, R. S., & Dalla-Favera, R. (1993). p53 mutations are associated with histologic transformation of follicular lymphoma. Blood, 82(8), 2289-2295. 

Lockmer, S., Ostenstad, B., Hagberg, H., Holte, H., Johansson, A. S., Wahlin, B. E., . . . Kimby, E. (2018). Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up. J Clin Oncol, Jco1800262. doi:10.1200/jco.18.00262

Lossos, I. S., & Gascoyne, R. D. (2011). Transformation of follicular lymphoma. Best Pract Res Clin Haematol, 24(2), 147-163. 

Lowry, L., Smith, P., Qian, W., Falk, S., Benstead, K., Illidge, T., . . . Hoskin, P. (2012). Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol, 100(1), 86-92. 

Ludmir, E. B., Milgrom, S. A., Pinnix, C. C., Gunther, J. R., Westin, J., Fayad, L. E., . . . Nastoupil, L. J. (2019). Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue. Clin Lymphoma Myeloma Leuk, 19(4), 244-250. doi:10.1016/j.clml.2018.12.016

Marcus, R., Imrie, K., Belch, A., Cunningham, D., Flores, E., Catalano, J., . . . Smith, P. (2005). CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood, 105(4), 1417-1423. 

Martinelli, G., Schmitz, S. F., Utiger, U., Cerny, T., Hess, U., Bassi, S., . . . Ghielmini, M. (2010). Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98. J Clin Oncol, 28(29), 4480-4484. 

Matutes, E., Martinez-Trillos, A., & Campo, E. (2015). Hairy cell leukaemia-variant: Disease features and treatment. Best Pract Res Clin Haematol, 28(4), 253-263. doi:10.1016/j.beha.2015.09.002

Meignan, M., Gallamini, A., Meignan, M., Gallamini, A., & Haioun, C. (2009). Report on the First International Workshop on Interim-PET-Scan in Lymphoma. Leuk Lymphoma, 50(8), 1257-1260. 

Meissner, J., Tichy, D., Katzke, V., Kuhn, T., Dietrich, S., Schmitt, T., . . . Ho, A. D. (2015). Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma. Ann Oncol, 26(8), 1771-1776. doi:10.1093/annonc/mdv227

Mir, M. A., Maurer, M. J., Ziesmer, S. C., Slager, S. L., Habermann, T., Macon, W. R., . . . Ansell, S. M. (2015). Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma. Blood, 125(6), 992-998. 

Montalban, C., Abraira, V., Arcaini, L., Domingo-Domenech, E., Guisado-Vasco, P., Iannitto, E., . . . Piris, M. A. (2012). Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases. Br J Haematol, 159(2), 164-171. doi:10.1111/bjh.12011

Montoto, S., Davies, A. J., Matthews, J., Calaminici, M., Norton, A. J., Amess, J., . . . Lister, T. A. (2007). Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol, 25(17), 2426-2433. 

Morschhauser, F., Fowler, N. H., Feugier, P., Bouabdallah, R., Tilly, H., Palomba, M. L., . . . Salles, G. A. (2018). Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma. N Engl J Med, 379(10), 934-947. doi:10.1056/NEJMoa1805104

Morton, L. M., Curtis, R. E., Linet, M. S., Bluhm, E. C., Tucker, M. A., Caporaso, N., . . . Fraumeni, J. F., Jr. (2010). Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol, 28(33), 4935-4944. 

Morton, L. M., Hartge, P., Holford, T. R., Holly, E. A., Chiu, B. C., Vineis, P., . . . Zheng, T. (2005). Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev, 14(4), 925-933. doi:10.1158/1055-9965.EPI-04-0693

Morton, L. M., Wang, S. S., Devesa, S. S., Hartge, P., Weisenburger, D. D., & Linet, M. S. (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 107(1), 265-276. 

Morton, L. M., Zheng, T., Holford, T. R., Holly, E. A., Chiu, B. C., Costantini, A. S., . . . InterLymph, C. (2005). Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol, 6(7), 469-476. doi:10.1016/S1470-2045(05)70214-X

Nabhan, C., Aschebrook-Kilfoy, B., Chiu, B. C., Kruczek, K., Smith, S. M., & Evens, A. M. (2014). The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras. Am J Hematol, 89(6), 633-638. 

Nakamura, S., Sugiyama, T., Matsumoto, T., Iijima, K., Ono, S., Tajika, M., . . . Asaka, M. (2012). Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut, 61(4), 507-513. doi:10.1136/gutjnl-2011-300495

Nationella Regimbiblioteket. Antitumorala regimer. Lymfom. Retrieved from http://regimbiblioteket.cancercentrum.se/regimregister.html?id=8

Nationella riktlinjer för prevention och behandling vid ohälsosamma levnadsvanor. Stöd för styrning och ledning. (2018). Retrieved from www.socialstyrelsen.se

Nomura, T., Huang, W. C., Zhau, H. E., Josson, S., Mimata, H., & Chung, L. W. (2014). beta2-Microglobulin-mediated signaling as a target for cancer therapy. Anticancer Agents Med Chem, 14(3), 343-352. 

Noy, A., de Vos, S., Thieblemont, C., Martin, P., Flowers, C. R., Morschhauser, F., . . . Chen, R. (2017). Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma. Blood, 129(16), 2224-2232. doi:10.1182/blood-2016-10-747345

Noy, A., Schoder, H., Gonen, M., Weissler, M., Ertelt, K., Cohler, C., . . . Yeung, H. W. (2009). The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Ann Oncol, 20(3), 508-512. 

O'Shea, D., O'Riain, C., Taylor, C., Waters, R., Carlotti, E., Macdougall, F., . . . Fitzgibbon, J. (2008). The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. Blood, 112(8), 3126-3129. 

Oh, S. Y., Ryoo, B. Y., Kim, W. S., Kim, K., Lee, J., Kim, H. J., . . . Park, K. (2006). Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma. Ann Hematol, 85(11), 781-786. doi:10.1007/s00277-006-0160-y

Oki, Y., Noorani, M., Lin, P., Davis, R. E., Neelapu, S. S., Ma, L., . . . Westin, J. R. (2014). Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol, 166(6), 891-901. 

Oktay, K., Cil, A. P., & Bang, H. (2006). Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril, 86(1), 70-80. doi:10.1016/j.fertnstert.2006.03.017

Oliansky, D. M., Gordon, L. I., King, J., Laport, G., Leonard, J. P., McLaughlin, P., . . . Hahn, T. (2010). The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review. Biol Blood Marrow Transplant, 16(4), 443-468. 

Olszewski, A. J., & Castillo, J. J. (2013). Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer, 119(3), 629-638. doi:10.1002/cncr.27773

Pangault, C., Ame-Thomas, P., Ruminy, P., Rossille, D., Caron, G., Baia, M., . . . Fest, T. (2010). Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis. Leukemia, 24(12), 2080-2089. 

Park, J. Y., Kim, S. G., Kim, J. S., & Jung, H. C. (2016). Bone marrow involvement is rare in superficial gastric mucosa-associated lymphoid tissue lymphoma. Dig Liver Dis, 48(1), 81-86. doi:10.1016/j.dld.2015.10.008

Pasqualucci, L., Khiabanian, H., Fangazio, M., Vasishtha, M., Messina, M., Holmes, A. B., . . . Dalla-Favera, R. (2014). Genetics of follicular lymphoma transformation. Cell Rep, 6(1), 130-140. 

Pedersen, M. O., Gang, A. O., Poulsen, T. S., Knudsen, H., Lauritzen, A. F., Nielsen, S. L., . . . Norgaard, P. (2012). Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience. Eur J Haematol, 89(1), 63-71. 

Persky, D. O., Dornan, D., Goldman, B. H., Braziel, R. M., Fisher, R. I., Leblanc, M., . . . Rimsza, L. M. (2012). Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone. Haematologica, 97(6), 937-942. 

Petrasch, S., Kosco, M., Perez-Alvarez, C., Schmitz, J., & Brittinger, G. (1992). Proliferation of non-Hodgkin-lymphoma lymphocytes in vitro is dependent upon follicular dendritic cell interactions. Br J Haematol, 80(1), 21-26. 

Petrich, A. M., Gandhi, M., Jovanovic, B., Castillo, J. J., Rajguru, S., Yang, D. T., . . . Abramson, J. S. (2014). Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood, 124(15), 2354-2361. 

Pinnix, C. C., Dabaja, B. S., Milgrom, S. A., Smith, G. L., Abou, Z., Nastoupil, L., . . . Esmaeli, B. (2017). Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head Neck, 39(6), 1095-1100. doi:10.1002/hed.24717

Press, O. W., Unger, J. M., Rimsza, L. M., Friedberg, J. W., LeBlanc, M., Czuczman, M. S., . . . Fisher, R. I. (2013). A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab. Clin Cancer Res, 19(23), 6624-6632. 

Pugh, T. J., Ballonoff, A., Newman, F., & Rabinovitch, R. (2010). Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: a Surveillance, Epidemiology, and End Results database analysis. Cancer, 116(16), 3843-3851. 

Raderer, M., Streubel, B., Wohrer, S., Hafner, M., & Chott, A. (2006). Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut, 55(5), 616-618. doi:10.1136/gut.2005.083022

Regueiro, C. A., Valcarcel, F. J., Romero, J., & de la Torre, A. (2002). Treatment of conjunctival lymphomas by beta-ray brachytherapy using a strontium-90-yttrium-90 applicator. Clin Oncol (R Coll Radiol), 14(6), 459-463. 

Robak, T., Matutes, E., Catovsky, D., Zinzani, P. L., & Buske, C. (2015). Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 26 Suppl 5, v100-107. doi:10.1093/annonc/mdv200

Rummel, M. J., Niederle, N., Maschmeyer, G., Banat, G. A., von Grunhagen, U., Losem, C., . . . Brugger, W. (2013). Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet, 381(9873), 1203-1210. 

Ruskone-Fourmestraux, A., Dragosics, B., Morgner, A., Wotherspoon, A., & De Jong, D. (2003). Paris staging system for primary gastrointestinal lymphomas. Gut, 52(6), 912-913. doi:10.1136/gut.52.6.912

Salar, A., Domingo-Domenech, E., Panizo, C., Nicolas, C., Bargay, J., Muntanola, A., . . . Montalban, C. (2017). Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma. Blood, 130(15), 1772-1774. doi:10.1182/blood-2017-07-795302

Salles, G., Seymour, J. F., Feugier, P., Offner, F., Lopez-Guillermo, A., Belada, D., . . . Delmer, A. (2017). Long Term Follow-up of the PRIMA Study: Half of Patients Receiving Rituximab Maintenance Remain Progression Free at 10 Years (Vol. 136): Blood.

Sarkozy, C., Baseggio, L., Feugier, P., Callet-Bauchu, E., Karlin, L., Seymour, J. F., . . . Salles, G. (2014). Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis. Br J Haematol, 164(5), 659-667. 

Schmatz, A. I., Streubel, B., Kretschmer-Chott, E., Puspok, A., Jager, U., Mannhalter, C., . . . Chott, A. (2011). Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol, 29(11), 1445-1451. 

Schmitter, D., Koss, M., Niederer, E., Stahel, R. A., & Pichert, G. (1997). T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells. Hematol Oncol, 15(4), 197-207. 

Schouten, H. C., Qian, W., Kvaloy, S., Porcellini, A., Hagberg, H., Johnson, H. E., . . . Kvalheim, G. (2003). High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J Clin Oncol, 21(21), 3918-3927. 

Scott, D. W., & Gascoyne, R. D. (2014). The tumour microenvironment in B cell lymphomas. Nat Rev Cancer, 14(8), 517-534. 

Sebban, C., Mounier, N., Brousse, N., Belanger, C., Brice, P., Haioun, C., . . . Coiffier, B. (2006). Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood, 108(8), 2540-2544. 

Sehn, L. H., Chua, N., Mayer, J., Dueck, G., Trneny, M., Bouabdallah, K., . . . Cheson, B. D. (2016). Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial. Lancet Oncol, 17(8), 1081-1093. doi:10.1016/s1470-2045(16)30097-3

Shiozawa, E., Yamochi-Onizuka, T., Yamochi, T., Yamamoto, Y., Naitoh, H., Kawakami, K., . . . Ota, H. (2003). Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein. Pathol Res Pract, 199(5), 293-302. 

Sinharay, R. (2003). Long term follow up of Helicobacter pylori induced gastric diffuse large B cell MALT lymphoma following eradication treatment alone. Gut, 52(9), 1385. doi:10.1136/gut.52.9.1385

Smedby, K. E., & Ponzoni, M. (2017). The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections. J Intern Med, 282(5), 360-370. doi:10.1111/joim.12684

Solal-Celigny, P., Cahu, X., & Cartron, G. (2010). Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful? Int J Hematol, 92(2), 246-254. 

Solal-Celigny, P., Roy, P., Colombat, P., White, J., Armitage, J. O., Arranz-Saez, R., . . . Montserrat, E. (2004). Follicular lymphoma international prognostic index. Blood, 104(5), 1258-1265. 

Starr, A. G., Caimi, P. F., Fu, P., Massoud, M. R., Meyerson, H., Hsi, E. D., . . . William, B. M. (2016). Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era. Br J Haematol, 175(2), 275-280. doi:10.1111/bjh.14228

Sureda, A., Bader, P., Cesaro, S., Dreger, P., Duarte, R. F., Dufour, C., . . . Madrigal, A. (2015). Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant, 50(8), 1037-1056. doi:10.1038/bmt.2015.6

Swerdlow, S. H. (2017). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer.

Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., . . . Jaffe, E. S. (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood, 127(20), 2375-2390. doi:10.1182/blood-2016-01-643569

Takada, M., Ichihara, T., Fukumoto, S., Nomura, H., & Kuroda, Y. (2003). Laparoscopy-assisted colon resection for mucosa-associated lymphoid tissue (MALT) lymphoma in the cecum. Hepatogastroenterology, 50(52), 1003-1005. 

Thieblemont, C., Molina, T., & Davi, F. (2016). Optimizing therapy for nodal marginal zone lymphoma. Blood, 127(17), 2064-2071. doi:10.1182/blood-2015-12-624296

Thompson, P. A., & Ravandi, F. (2017). How I manage patients with hairy cell leukaemia. Br J Haematol, 177(4), 543-556. doi:10.1111/bjh.14524

Trotman, J., Fournier, M., Lamy, T., Seymour, J. F., Sonet, A., Janikova, A., . . . Salles, G. (2011). Positron Emission Tomography–Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants. Journal of Clinical Oncology, 29(23), 3194-3200. doi:10.1200/jco.2011.35.0736

Trotman, J., Luminari, S., Boussetta, S., Versari, A., Dupuis, J., Tychyj, C., . . . Meignan, M. (2014). Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies. The Lancet Haematology, 1(1), e17-e27. 

Tsang, R. W., Gospodarowicz, M. K., Pintilie, M., Bezjak, A., Wells, W., Hodgson, D. C., & Crump, M. (2001). Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys, 50(5), 1258-1264. 

Tsang, R. W., Gospodarowicz, M. K., Pintilie, M., Wells, W., Hodgson, D. C., Sun, A., . . . Patterson, B. J. (2003). Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol, 21(22), 4157-4164. doi:10.1200/jco.2003.06.085

Umetsu, D. T., Esserman, L., Donlon, T. A., DeKruyff, R. H., & Levy, R. (1990). Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol, 144(7), 2550-2557. 

Wahlin, B. E., Aggarwal, M., Montes-Moreno, S., Gonzalez, L. F., Roncador, G., Sanchez-Verde, L., . . . Kimby, E. (2010). A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res, 16(2), 637-650. 

Wahlin, B. E., Sander, B., Christensson, B., & Kimby, E. (2007). CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma. Clin Cancer Res, 13(2 Pt 1), 388-397. 

Wahlin, B. E., Sander, B., Christensson, B., Ostenstad, B., Holte, H., Brown, P. D., . . . Kimby, E. (2012). Entourage: the immune microenvironment following follicular lymphoma. Blood Cancer J, 2(1), e52. 

Wahlin, B. E., Sundstrom, C., Holte, H., Hagberg, H., Erlanson, M., Nilsson-Ehle, H., . . . Kimby, E. (2011). T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab. Clin Cancer Res, 17(12), 4136-4144. 

Wahlin, B. E., Sundstrom, C., Sander, B., Christensson, B., Jeppsson-Ahlberg, A., Hjalmarsson, E., . . . Kimby, E. (2014). Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy. Leuk Lymphoma, 55(2), 288-295. 

Wahlin, B. E., Yri, O. E., Kimby, E., Holte, H., Delabie, J., Smeland, E. B., . . . Sander, B. (2012). Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times. Br J Haematol, 156(2), 225-233. 

Vajdic, C. M., van Leeuwen, M. T., Turner, J. J., McDonald, A. M., Webster, A. C., McDonald, S. P., . . . Grulich, A. E. (2010). No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency. Int J Cancer, 127(11), 2732-2735. 

van Oers, M. H., Van Glabbeke, M., Giurgea, L., Klasa, R., Marcus, R. E., Wolf, M., . . . Hagenbeek, A. (2010). Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study. J Clin Oncol, 28(17), 2853-2858. 

Wang, L., Xia, Z. J., Zhang, Y. J., Huang, H. Q., Lin, T. Y., & Lu, Y. (2015). Radical surgery may be not an optimal treatment approach for pulmonary MALT lymphoma. Tumour Biol, 36(8), 6409-6416. doi:10.1007/s13277-015-3329-y

Watanabe, N., Narimatsu, H., Noh, J. Y., Iwaku, K., Kunii, Y., Suzuki, N., . . . Ito, K. (2018). Long-Term Outcomes of 107 Cases of Primary Thyroid Mucosa-Associated Lymphoid Tissue Lymphoma at a Single Medical Institution in Japan. J Clin Endocrinol Metab, 103(2), 732-739. doi:10.1210/jc.2017-01478

Vermaete, N., Wolter, P., Verhoef, G., & Gosselink, R. (2013). Physical activity, physical fitness and the effect of exercise training interventions in lymphoma patients: a systematic review. Ann Hematol, 92(8), 1007-1021. doi:10.1007/s00277-013-1689-1

Vetro, C., Chiarenza, A., Romano, A., Amico, I., Calafiore, V., Di Raimondo, C., . . . Di Raimondo, F. (2014). Prognostic assessment and treatment of primary gastric lymphomas: how endoscopic ultrasonography can help in tailoring patient management. Clin Lymphoma Myeloma Leuk, 14(3), 179-185. doi:10.1016/j.clml.2013.10.010

Vidal, L., Gafter-Gvili, A., Leibovici, L., Dreyling, M., Ghielmini, M., Hsu Schmitz, S. F., . . . Shpilberg, O. (2009). Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst, 101(4), 248-255. 

Villa, D., Crump, M., Panzarella, T., Savage, K. J., Toze, C. L., Stewart, D. A., . . . Kuruvilla, J. (2013). Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group. J Clin Oncol, 31(9), 1164-1171. 

Willemze, R., Swerdlow, S. H., Harris, N. L., & Verger, B. (2008). Primary cutaneous follicle centre lymphoma. In S. H. Swerdlow, E. Campo, N. L. Harris, E. S. Jaffe, S. A. Pileri, H. Stein, J. Thiele, & J. W. Vardiman (Eds.), WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (pp. 227-228). Lyon: IARC.

Villeneuve, A., Rubin, F., & Bonfils, P. (2018). Meningeal marginal zone B-cell lymphoma: The meningioma trap. Eur Ann Otorhinolaryngol Head Neck Dis, 135(2), 131-132. doi:10.1016/j.anorl.2017.12.002

Wirk, B., Fenske, T. S., Hamadani, M., Zhang, M. J., Hu, Z. H., Akpek, G., . . . Saber, W. (2014). Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biol Blood Marrow Transplant, 20(7), 951-959. 

Wirth, A., Gospodarowicz, M., Aleman, B. M., Bressel, M., Ng, A., Chao, M., . . . Zucca, E. (2013). Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study. Ann Oncol, 24(5), 1344-1351. doi:10.1093/annonc/mds623

Wohrer, S., Kiesewetter, B., Fischbach, J., Mullauer, L., Troch, M., Lukas, J., . . . Raderer, M. (2014). Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis. Ann Hematol, 93(8), 1287-1295. doi:10.1007/s00277-014-2042-z

Wundisch, T., Thiede, C., Morgner, A., Dempfle, A., Gunther, A., Liu, H., . . . Neubauer, A. (2005). Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol, 23(31), 8018-8024. doi:10.1200/jco.2005.02.3903

Yamamoto, S., Nakase, H., Yamashita, K., Matsuura, M., Takada, M., Kawanami, C., & Chiba, T. (2010). Gastrointestinal follicular lymphoma: review of the literature. J Gastroenterol, 45(4), 370-388. 

Yri, O. E., Torfoss, D., Hungnes, O., Tierens, A., Waalen, K., Nordoy, T., . . . Kolstad, A. (2011). Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood, 118(26), 6769-6771. doi:10.1182/blood-2011-08-372649

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., . . . Thieblemont, C. (2017). Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. J Clin Oncol, 35(17), 1905-1912. doi:10.1200/jco.2016.70.6994

Zucca, E., Copie-Bergman, C., Ricardi, U., Thieblemont, C., Raderer, M., & Ladetto, M. (2013). Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 24 Suppl 6, vi144-148. doi:10.1093/annonc/mdt343

Zucca, E., Rondeau, S., Vanazzi, A., Ostenstad, B., Mey, U. J. M., Rauch, D., . . . Kimby, E. (2019). Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy. Blood, 134(4), 353-362. doi:10.1182/blood-2018-10-879643

Zuckerman, E., Zuckerman, T., Douer, D., Qian, D., & Levine, A. M. (1998). Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer, 83(6), 1224-1230. 

Nästa kapitel
28 Vårdprogramgruppen